The SPIRE Advisory Group guides Technology, Agriscience, digital health, medical devices, diagnostics and biotech Start-ups from the idea phase to commercialization/international distribution.
Expertise in all facets of Technology. Our venture advisors practice and teach at Stanford, UCSF as well as various international institutions, and our network of distributors and partners spans all continents.
ABOUT SPIRE ADVISORY GROUP
The SPIRE Advisory partners have extensive and complementary experience in business strategy for start-ups and midsize companies looking for strategic partnerships and global exposure.
The SPIRE Advisory Network is a group of dedicated equity partners who work together in a closed network, serving companies as international consultants, advisors and board members. Spire Advisory facilitates key transitions across a company’s lifecycle.
The SPIRE Advisory expertise spans from the life science field to Agroscience, but also includes AI, DeepTech and blockchain through a wide network of experts in the San Francisco Bay Area as well as strategically located worldwide.
The unique SPIRE Advisory model enables our partners to quickly connect with each other and to efficiently develop the best insights and recommendations.
LATEST NEWS
November 14th, 2024 – The Canadian Entrepreneurs in Life Sciences hosted the Valley Ready Cohort 16 1-on-1 investors meetings at the EY Tech University in Palo Alto, CA. The Valley Ready program and investors meetings was managed by SPIRE Advisory Team, Connections Silicon Valley and the CELS Leadership team.
November 1st, 2024 – It was a a pleasure partnering with Blueprint Creative Group and U.S. Trade and Development Agency (USTDA) on a US Vietnam Healthcare workshop.
It was enlightening to engage with the Vietnam Ministry of Health, the US FDA and private sector on challenges and opportunities in the era of AI and digital health.
April 4th, 2024 – We were delighted to contribute to the USTDA healthcare workshop in Bangkok, by mobilising key stakeholders to the table. The most significant outcome from the various workshops involving government, industry and regulatory bodies is that incentivizing health innovation is key to improving health outcomes and reducing costs in developing countries.
